ASKA Pharmaceutical Holdings Co., Ltd. (4514) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

JCR Pharmaceuticals Co., Ltd.

Zeria Pharmaceutical Co., Ltd.

ASKA Pharmaceutical Holdings Co., Ltd.

Katakura Industries Co., Ltd.

Mochida Pharmaceutical Co., Ltd.

Torii Pharmaceutical Co., Ltd.

Nxera Pharma Co., Ltd.

Towa Pharmaceutical Co., Ltd.

Earth Corp.

KYORIN Pharmaceutical Co., Ltd.

Kaken Pharmaceutical Co., Ltd.

Why is ASKA Pharmaceutical Holdings Co., Ltd. ?

Company has very low debt and has enough cash to service the debt requirements

Healthy long term growth as Operating profit has grown by an annual rate 4.76%

The company has declared Negative results for the last 6 consecutive quarters

CASH AND EQV(HY) Lowest at JPY 17,603 MM
INVENTORY TURNOVER RATIO(HY) Lowest at 1.33 times
INTEREST(Q) Highest at JPY 60 MM

With ROE of 7.76%, it has a very attractive valuation with a 0.96 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -10.93%, its profits have risen by 2.8% ; the PEG ratio of the company is 1.3
At the current price, the company has a high dividend yield of 0

Below par performance in long term as well as near term

Along with generating -10.93% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to ASKA Pharmaceutical Holdings Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is ASKA Pharmaceutical Holdings Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

ASKA Pharmaceutical Holdings Co., Ltd.

-10.93%

-0.15

37.55%

Japan Nikkei 225

85.83%

3.09

27.80%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

4.67%

EBIT Growth (5y)

4.76%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

0.17

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.86

Tax Ratio

17.62%

Dividend Payout Ratio

30.56%

Pledged Shares

Institutional Holding

ROCE (avg)

9.64%

ROE (avg)

11.79%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.96

EV to EBIT

15.34

EV to EBITDA

9.75

EV to Capital Employed

0.96

EV to Sales

1.06

PEG Ratio

1.33

Dividend Yield

ROCE (Latest)

6.26%

ROE (Latest)

7.76%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

Bullish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

DEBTORS TURNOVER RATIO(HY)

Highest at 4.58 times

DIVIDEND PER SHARE(HY)

Highest at JPY 4.58

NET SALES(Q)

At JPY 16,641 MM has Grown at 17.08%

PRE-TAX PROFIT(Q)

Highest at JPY 2,285 MM

NET PROFIT(Q)

Highest at JPY 1,710.8 MM

-13What is not working for the Company

CASH AND EQV(HY)

Lowest at JPY 17,603 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.33 times

INTEREST(Q)

Highest at JPY 60 MM

Here's what is working for ASKA Pharmaceutical Holdings Co., Ltd.

Net Sales

At JPY 16,641 MM has Grown at 17.08%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (JPY MM)

Pre-Tax Profit

Highest at JPY 2,285 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (JPY MM)

Pre-Tax Profit

At JPY 2,285 MM has Grown at 118.45%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (JPY MM)

Net Profit

Highest at JPY 1,710.8 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (JPY MM)

Debtors Turnover Ratio

Highest at 4.58 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Dividend per share

Highest at JPY 4.58

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (JPY)

Depreciation

Highest at JPY 792 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for ASKA Pharmaceutical Holdings Co., Ltd.

Interest

At JPY 60 MM has Grown at 13.21%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Interest

Highest at JPY 60 MM

in the last five periods and Increased by 13.21% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Cash and Eqv

Lowest at JPY 17,603 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio

Lowest at 1.33 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio